Abstract

BackgroundBile acids (BAs) regulate hepatic lipid metabolism and inflammation. Bile salt export pump (BSEP) KO mice are metabolically preconditioned with a hydrophilic BA composition protecting them from cholestasis. We hypothesize that changes in hepatic BA profile and subsequent changes in BA signalling may critically determine the susceptibility to steatohepatitis.MethodsWild‐type (WT) and BSEP KO mice were challenged with methionine choline‐deficient (MCD) diet to induce steatohepatitis. Serum biochemistry, lipid profiling as well as intestinal lipid absorption were assessed. Markers of inflammation, fibrosis, lipid and BA metabolism were analysed. Hepatic and faecal BA profile as well as serum levels of the BA synthesis intermediate 7‐hydroxy‐4‐cholesten‐3‐one (C4) were also investigated.ResultsBile salt export pump KO MCD‐fed mice developed less steatosis but more inflammation than WT mice. Intestinal neutral lipid levels were reduced in BSEP KO mice at baseline and under MCD conditions. Faecal non‐esterified fatty acid concentrations at baseline and under MCD diet were markedly elevated in BSEP KO compared to WT mice. Serum liver enzymes and hepatic expression of inflammatory markers were increased in MCD‐fed BSEP KO animals. PPARα protein levels were reduced in BSEP KO mice. Accordingly, PPARα downstream targets Fabp1 and Fatp5 were repressed, while NFκB subunits were increased in MCD‐fed BSEP KO mice. Farnesoid X receptor (FXR) protein levels were reduced in MCD‐fed BSEP KO vs WT mice. Hepatic BA profile revealed elevated levels of TβMCA, exerting FXR antagonistic action, while concentrations of TCA (FXR agonistic function) were reduced.ConclusionPresence of hydroxylated BAs result in increased faecal FA excretion and reduced hepatic lipid accumulation. This aggravates development of MCD diet‐induced hepatitis potentially by decreasing FXR and PPARα signalling.

Highlights

  • Non-alcoholic fatty liver disease (NAFLD) comprises a wide disease spectrum ranging from simple steatosis to steatohepatitis (NASH), fibrosis, cirrhosis and cancer.[1,2,3] The mechanisms underlying the progression from benign steatosis to NASH and more advanced disease stages are still poorly understood

  • Presence of hydroxylated bile acid (BA) result in increased faecal fatty acids (FAs) excretion and reduced hepatic lipid accumulation

  • Since methionine choline-deficient (MCD) feeding was shown to interfere with BA metabolism,[39] recently found to be involved in progression of NASH,[20] expression of key determinants of BA homeostasis, such as Cyp27a1, Cyp2c70 and Cyp7a1, Cyp8b1

Read more

Summary

Introduction

Non-alcoholic fatty liver disease (NAFLD) comprises a wide disease spectrum ranging from simple steatosis to steatohepatitis (NASH), fibrosis, cirrhosis and cancer.[1,2,3] The mechanisms underlying the progression from benign steatosis to NASH and more advanced disease stages are still poorly understood. Polyunsaturated FAs serve as ligands for PPARα,[5] which correlate negatively with the severity of NASH in humans.[6] a beneficial role of PPARα and PPARδ agonists has been demonstrated in several (pre)clinical NAFLD/NASH studies.[7,8,9,10,11] bile acids (BAs), via signalling through their dedicated nuclear receptor farnesoid X receptor (FXR; NR1H4) as key regulator of glucose and lipid metabolism, as well as inflammation[12,13,14,15,16,17] may play an important role in the pathogenesis and treatment of NAFLD/NASH. Intestinal neutral lipid levels were reduced in BSEP KO mice at baseline and under MCD conditions. Farnesoid X receptor (FXR) protein levels were reduced in MCD-fed BSEP KO vs WT mice. Hepatic BA profile revealed elevated levels of TβMCA, exerting FXR antagonistic action, while concentrations of TCA (FXR agonistic function) were reduced

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call